A. W. Harris

发表

Mutations in the p53 and SCID genes cooperate in tumorigenesis.

T. Jacks, A. Strasser, R. Bronson, 1996, Genes & development.

Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.

A. Strasser, A. W. Harris, S. Cory, 1994, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

R. Palmiter, W. Alexander, A. W. Harris, 1985, Nature.

Immunoglobulin Gene Expression in Murine Lymphoid Cells

A. W. Harris, N. Warner, 1973 .

Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes

T. Metz, A. W. Harris, Jerry M. Adams, 1995, Cell.

Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields.

A Basten, V. Gebski, M. Repacholi, 1997, Radiation research.

Progenitor tumours from Emu‐bcl‐2‐myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival.

A. Elefanty, A. Strasser, A. W. Harris, 1996, The EMBO journal.

Immunoglobulin production by murine B-lymphoma cells.

G. Gutman, A. W. Harris, N. Warner, 1981, Clinical immunology and immunopathology.

Enforced Bcl-2 Expression Inhibits Antigen-mediated Clonal Elimination of Peripheral B Cells in an Antigen Dose–dependent Manner and Promotes Receptor Editing in Autoreactive, Immature B Cells

S. Korsmeyer, A. Strasser, D. Nemazee, 1997, The Journal of experimental medicine.

Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice.

D. Vaux, A. Strasser, A. W. Harris, 1990, Current topics in microbiology and immunology.

Transferrin promotion of 67Ga and 59Fe uptake by cultured mouse myeloma cells.

A. W. Harris, R. Sephton, 1977, Cancer research.

Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.

C. Print, A. W. Harris, Jerry M. Adams, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy.

A. W. Harris, S. Cory, W. Langdon, 1988, Oncogene research.

A bcr-v-abl oncogene induces lymphomas in transgenic mice

I. Hariharan, A. W. Harris, S. Cory, 1989, Molecular and cellular biology.

CD95 (Fas/APO-1) and p53 signal apoptosis independently in diverse cell types.

A. Strasser, A. W. Harris, L. O’Connor, 2000, Cancer research.

Glucocorticoid Receptors in Lymphoma Cells in Culture: Relationship to Glucocorticoid Killing Activity

M. Cohn, J. Baxter, A. W. Harris, 1971, Science.

Genetic studies on Emu-myc transgenic mice.

J. D. Marshall, A. W. Harris, C. Sidman, 1988, Current topics in microbiology and immunology.

Transgenic mouse models for hematopoietic tumorigenesis.

D. Vaux, I. Hariharan, W. Alexander, 1988, Current topics in microbiology and immunology.

Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins.

C. Print, A. Strasser, P. Bouillet, 1999, Cold Spring Harbor symposia on quantitative biology.

Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene.

A. Strasser, A. W. Harris, S. Cory, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Mouse myelomas and lymphomas in culture.

A. W. Harris, K. Horibata, 1970, Experimental cell research.

FADD and caspase-8 are required for cytokine-induced proliferation of hemopoietic progenitor cells.

A. Strasser, A. W. Harris, M. Pellegrini, 2005, Blood.

Cyclin D1 as the putative bcl-1 oncogene.

A. W. Harris, J. M. Adams, G. Lindeman, 1995, Current topics in microbiology and immunology.

bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8- T cell progenitors.

A. Strasser, A. W. Harris, L. O'Reilly, 1997, International immunology.

Gallium-67 citrate uptake by cultured tumor cells, stimulated by serum transferrin.

A. W. Harris, R. Sephton, 1975, Journal of the National Cancer Institute.

Retroviral infection accelerates T lymphomagenesis in E mu-N-ras transgenic mice by activating c-myc or N-myc.

Y. Haupt, A. W. Harris, J. M. Adams, 1992, Oncogene.

Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

G. Wong, A. W. Harris, J. Schrader, 1983, Journal of immunology.

Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development.

A. W. Harris, N. Koch, 1984, Journal of immunology.

Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice.

W. Alexander, A. W. Harris, S. Cory, 1989, Haematology and blood transfusion.

Studies on the uptake of 67 Ga and 59 Fe and the binding of transferrin by cultured mouse tumour cells.

A. W. Harris, R. Sephton, 1981, International journal of nuclear medicine and biology.

The immunoglobulin μ constant region gene is expressed in mouse thymocytes

A. W. Harris, D. Kemp, K. Shortman, 1980, Nature.

Production of RNA for secreted immunoglobulin μ chains does not require transcriptional termination 5′ to the μM exons

G. Morahan, A. Cowman, A. W. Harris, 1983, Nature.

c-myc-induced lymphomagenesis in transgenic mice and the role of the Pvt-1 locus in lymphoid neoplasia.

R. Palmiter, W. Alexander, A. W. Harris, 1986, Current topics in microbiology and immunology.

Bcl-2 expression promotes B- but not T-lymphoid development in scid mice

A. Strasser, A. W. Harris, S. Cory, 1994, Nature.

Intermediate steps in thymic positive selection. Generation of CD4-8+ T cells in culture from CD4+8+, CD4int8+, and CD4+8int thymocytes with up-regulated levels of TCR-CD3.

A. W. Harris, K. Shortman, D. Vremec, 1995, Journal of immunology.

Enforced BCL 2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease ( oncogene / transgenic mice / lymphocyte lifespan / lupus mkce / glomerulonephritis )

D. Vaux, A. Strasser, A. W. Harris, 2022 .

Receptors for immunoglobulin on B lymphocytes and cells of a cultured plasma cell tumor.

J. Sprent, A. W. Harris, N. Warner, 1972, Journal of immunology.

the Hematopoietic Compartment Drive Transgene Expression In Vivo Throughout vav Promoter Elements of

A. W. Harris, Jerry M. Adams, D. Metcalf, 2010 .

Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.

A. W. Harris, J. M. Adams, D. Metcalf, 1999, Blood.

Effect of cloned interferon‐γ on expression of H‐2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin

G. Wong, A. W. Harris, J. Schrader, 1984, European journal of immunology.

Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice.

J. Downing, P. Pandolfi, R. M. Simpson, 2002, Blood.

Atlas Of Mouse Hematopathology

A. W. Harris, T. Fredrickson, 2000 .

Subunit structure of cell surface proteins: disulfide bonding in antigen receptors, Ly-2/3 antigens, and transferrin receptors of murine T and B lymphocytes.

A. W. Harris, J. Goding, 1981, Proceedings of the National Academy of Sciences of the United States of America.

hemopoietic progenitor cells FADD and caspase-8 are required for cytokine-induced proliferation of

A. Strasser, A. W. Harris, M. Pellegrini, 2013 .

Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells

A. Strasser, A. W. Harris, C. Kurts, 2001, Current Biology.

Immunoglobulin of T lymphoma cells. Biosynthesis, surface representation, and partial characterization.

J. Marchalonis, A. W. Harris, D. Haustein, 1975, Biochemistry.

Perturbed development of T and B cells in mice expressing an Hlx homeobox transgene.

A. Strasser, A. W. Harris, J. M. Adams, 1995, Journal of immunology.

An E mu‐v‐abl transgene elicits plasmacytomas in concert with an activated myc gene.

J.M. Adams, A. W. Harris, S. Cory, 1990, The EMBO journal.

Transgenic Mice as Models for the Development of Haemopoietic Neoplasia

D. Vaux, A. W. Harris, S. Cory, 1989 .

Lymphoid neoplasia and the control of haemopoietic differentiation.

D. Vaux, I. Hariharan, W. Alexander, 1989, Ciba Foundation symposium.

The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice.

W. Alexander, A. W. Harris, S. Cory, 1987, Haematology and blood transfusion.

Lessons from Translocations and Transgenic Mice: Constitutive c-myc Expression Predisposes to Neoplasia

J.M. Adams, W. Alexander, A. W. Harris, 1986 .

Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.

J.M. Adams, A. W. Harris, Jerry M. Adams, 1994, The EMBO journal.

Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice.

R. Eisenman, A. W. Harris, Jerry M. Adams, 1995, Oncogene.

MOLECULAR PROPERTIES OF T LYMPHOMA IMMUNOGLOBULIN

J. Marchalonis, A. W. Harris, J. Moseley, 1977, Journal of immunogenetics.

Acceleration of B-lymphoid tumorigenesis in E mu-myc transgenic mice by v-H-ras and v-raf but not v-abl.

A. W. Harris, S. Cory, W. Langdon, 1989, Oncogene research.

Use of [75Se]selenomethionine in immunoglobulin biosynthetic studies.

G. Gutman, A. W. Harris, N. Warner, 1978, Journal of immunological methods.

Immunoglobulin Cμ RNA in T lymphoma cells is not translated

A. W. Harris, I. Walker, 1980, Nature.

The Role of bcl — 2 in Lymphoid Differentation and Transformation

A. Strasser, A. W. Harris, S. Cory, 1993 .

Lymphomas and plasmacytomas in transgenic mice involving bcl2, myc and v-abl.

A. Strasser, A. W. Harris, S. Cory, 1997, Current Topics in Microbiology and Immunology.

The role of bcl-2 in lymphoid differentiation and neoplastic transformation.

A. Strasser, A. W. Harris, S. Cory, 1992, Current topics in microbiology and immunology.

Enhanced cell survival and tumorigenesis.

T. Jacks, A. Strasser, A. W. Harris, 1994, Cold Spring Harbor Symposia on Quantitative Biology.

MYC levels govern hematopoietic tumor type and latency in transgenic mice.

A. W. Harris, S. Cory, Darrin P. Smith, 2006, Blood.

DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2

T. Jacks, A. Strasser, A. W. Harris, 1994, Cell.

Deoxyribonucleoside triphosphate pools and differential thymidine sensitivities of cultured mouse lymphoma and myeloma cells.

L. R. Finch, A. W. Harris, E. C. Reynolds, 1979, Biochimica et biophysica acta.

Effect of thymidine on the sensitivity of cultured mouse tumor cells to 1-beta-D-arabinofuranosylcytosine.

L. R. Finch, A. W. Harris, E. C. Reynolds, 1979, Cancer research.

Bethesda proposals for classification of lymphoid neoplasms in mice.

N. Harris, E. Jaffe, J. Ward, 2002, Blood.

Mechanism of glucocorticoid action: general features, with reference to steroid-mediated immunosuppression.

J. Baxter, A. W. Harris, 1975, Transplantation proceedings.

Cell-mediated immune response in vitro. II. The role of thymus and thymus-derived lymphocytes.

M. Feldmann, A. W. Harris, H. Wagner, 1972, Cellular immunology.

Alkaline phosphatase in hematopoietic tumor cell lines of the mouse: high activity in cells of the B lymphoid lineage.

A. W. Harris, J. Culvenor, A. Whitelaw, 1981, Journal of immunology.

INHIBITION OF A T-CELL-DEPENDENT IMMUNE RESPONSE IN VITRO BY THYMOMA CELL IMMUNOGLOBULIN

J. Marchalonis, A. W. Harris, J. Stocker, 1974, The Journal of experimental medicine.

Cells of some cultured lymphoma lines are killed rapidly by x-rays and by bleomycin.

J. Lowenthal, A. W. Harris, 1982, International journal of radiation biology and related studies in physics, chemistry, and medicine.

Differentiated functions expressed by cultured mouse lymphoma cells. I. Specificity and kinetics of cell responses to corticosteroids.

A. W. Harris, 1970, Experimental cell research.

bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship

Suzanne Cory, A. Strasser, A. W. Harris, 1991, Cell.

Growth Control of Hemopoietic Colony-Forming Cells by Thymidine and Deoxycytidine

A. W. Harris, S. Hasthorpe, 1979 .

The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

A. W. Harris, W. Langdon, J. M. Adams, 1988, The Journal of experimental medicine.

VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

A. W. Harris, S. Cory, A. Egle, 2004, Blood.

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

D. Vaux, A. Strasser, A. W. Harris, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in Eμ-v-abl transgenic mice

Jane Fridlyand, Terence P Speed, Mark J Daly, 2002, Proceedings of the National Academy of Sciences of the United States of America.

FADD/MORT1 regulates the pre‐TCR checkpoint and can function as a tumour suppressor

A. Strasser, A. W. Harris, K. Newton, 2000, The EMBO journal.

Insights from Bcl-2 and Myc: malignancy involves abrogation of apoptosis as well as sustained proliferation.

D. Vaux, A. Strasser, A. W. Harris, 1999, Cancer research.

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

A. Strasser, A. W. Harris, S. Cory, 1990, Nature.

N‐myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross‐regulation with c‐myc.

A. W. Harris, S. Cory, J. M. Adams, 1989, The EMBO journal.

The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice

A. W. Harris, S. Cory, Jerry M. Adams, 1986, Cell.

E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells.

A. Strasser, A. W. Harris, S. Cory, 1993, Oncogene.

T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC

A. W. Harris, S. Cory, Darrin P. Smith, 2005, Oncogene.

A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes

Kenneth G. C. Smith, A. Strasser, A. W. Harris, 1998, The EMBO journal.

Contribution of the Cyclin D1 Gene to Lymphomagenesis

A. W. Harris, Jerry M. Adams, G. Lindeman, 1995 .

Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo.

A. Strasser, A. W. Harris, D. Tarlinton, 1997, Journal of immunology.

Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research.

A. Strasser, A. W. Harris, S. Cory, 1996, Behring Institute Mitteilungen.

Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis.

A. Strasser, P. Krammer, A. W. Harris, 1995, The EMBO journal.

Elimination of self-reactive B lymphocytes proceeds in two stages: Arrested development and cell death

M. Cooke, C. Goodnow, A. W. Harris, 1993, Cell.

bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.

Y. Haupt, A. W. Harris, Jerry M. Adams, 1993, Oncogene.

Differentiated functions expressed by cultured mouse lymphoma cells. II. Theta antigen, surface immunoglobulin and a receptor for antibody on cells of a thymoma cell line.

A. W. Harris, A. Bankhurst, N. Warner, 1973, Journal of immunology.

Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines.

D. Kemp, A. W. Harris, S. Cory, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector

A. Strasser, A. W. Harris, S. Cory, 1999, Oncogene.

Generation of long mRNA for membrane immunoglobulin γ2a chains by differential splicing

A. Cowman, A. W. Harris, Jerry M. Adams, 1981, Nature.

Subversion of the Bcl-2 life/death switch in cancer development and therapy.

A. Strasser, P. Colman, P. Bouillet, 2005, Cold Spring Harbor symposia on quantitative biology.

Bim is a suppressor of Myc-induced mouse B cell leukemia.

P. Bouillet, A. W. Harris, S. Cory, 2004, Proceedings of the National Academy of Sciences of the United States of America.

B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain.

A. W. Harris, S. Cory, J. M. Adams, 1994, Immunity.

Lymphoid tumorigenesis by v-abl and BCR-v-abl in transgenic mice.

A. W. Harris, J. M. Adams, M. Bath, 1990, Current topics in microbiology and immunology.

Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment.

J. Visvader, A. Elefanty, A. W. Harris, 1998, Blood.

SPECULATIONS ON THE FUNCTION OF IMMUNE RESPONSE GENES

J. Marchalonis, A. W. Harris, P. Morris, 1974 .

Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation.

J. Lowenthal, A. W. Harris, 1985, Journal of immunology.

Transferrin Promotion of 67 Gaand 59 FeUptake by Cultured MouseMyelomaCells 1

A. W. Harris, R. Sephton, 2022 .

Transcripts of the immunoglobulin C mu gene vary in structure and splicing during lymphoid development.

D. Kemp, A. W. Harris, J. M. Adams, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Detection of a possible precursor of immunoglobulin light chain in MOPC 41 a plasmacytoma cells

A. W. Harris, J. M. Adams, B. Schmeckpeper, 1975, FEBS letters.

A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields.

V. Gebski, M. Repacholi, A. W. Harris, 1998, Radiation research.

CD4+8- and CD4-8+ mature thymocytes require different post-selection processing for final development.

A. Strasser, A. W. Harris, H. Petrie, 1993, Journal of immunology.

Ga-67 and Fe-59 distributions in mice.

A. W. Harris, R. Sephton, G. Hodgson, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Transferrin promotion of /sup 67/Ga and /sup 59/Fe uptake by cultured mouse myeloma cells

A. W. Harris, R. Sephton, 1977 .

CELL SURFACE IMMUNOGLOBULIN OF MOUSE T LYMPHOMA CELLS AND CULTURED FETAL THYMOCYTES

J. Marchalonis, A. W. Harris, T. Mandel, 1976 .

In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.

B. Rouse, A. W. Harris, H. Wagner, 1972, Journal of immunology.

Moloney virus induction of T‐cell lymphomas in a plasmacytomagenic strain of Eμ‐V‐ABL transgenic mice

Y. Haupt, A. W. Harris, Jerry M. Adams, 1993, International journal of cancer.

INHIBITION O F A T-CELL-DEPENDENT I MMUNE R ESPONSE I N VITRO B Y T HYMOMA C ELL I MMUNOGLOBULIN*

J. Marchalonis, A. W. Harris, J. Stocker, 1974 .

Expression of the immunoglobulin C , gene in mouse T and B lymphoid and myeloid cell lines ( p and K mRNA species / hibridization / recombinant DNA / rearranged genes )

A. W. Harris, S. Cory, Jerry M. Adams, 2022 .

INHIBITION OF A T-CELL-DEPENDENT IMMUNE RESPONSE IN VITRO BY THYMOMA CELL IMMUNOGLOBULIN

J. Marchalonis, A. W. Harris, J. Stocker, 1974, The Journal of experimental medicine.

mu Polypeptide phenotypes of lymphoid and myeloid cell lines containing RNA transcripts of the immunoglobulin C mu gene.

A. W. Harris, I. Walker, 1981, Journal of immunology.